Abstract
The proteinase activity of strains of group A streptococci isolated from patients in acute and convalescent phases of illness was found to be remarkably constant. Sulfadiazine therapy of patients did not affect proteinase production by the infecting streptococci. The ability to produce streptococcal proteinase would appear to be related to the strain and not necessarily to the serological type. No relationship could be found between the capacity of group A streptococci of different serological types to produce proteinase and the various clinical responses to infection with these microorganisms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
